ReviewCurrent opinion in endocrinology, diabetes, and obesity2013
A complications-based clinical staging of obesity to guide treatment modality and intensity.
Review in Current opinion in endocrinology, diabetes, and obesity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05420506 (Treatment of Obesity Without Surgical Intervention by Reversible Reduction of the Small Intestinal Absorption Area), which is not on this map. Cited by 33 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Treatment of Obesity Without Surgical Intervention by Reversible Reduction of the Small Intestinal Absorption Area
Who cites it
33 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Effects of the ketogenic diet on bone health: A systematic review.Frontiers in endocrinology · 2023Pooled it
- Left gastric artery embolization for obesity treatment: a systematic review and meta-analysis of human and animal studies.Abdominal radiology (New York) · 2021Pooled it
- The Effectiveness of Endoscopic Gastroplasty for Obesity Treatment According to FDA Thresholds: Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.Obesity surgery · 2018Pooled it
- Obesity in the Workplace: Impact, Outcomes, and Recommendations.Journal of occupational and environmental medicine · 2018Guideline
- Endoscopic sleeve gastroplasty versus intragastric balloon insertion as bridge-to-surgery procedures for patients with BMI ≥50 kg/mTherapeutic advances in gastroenterology · 2026Article
- Analysis of the Resolution Rate of Complications in Obese Joint Replacement Patients.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2025Article
- Introduction and methodology: Standards of Care in Overweight and Obesity-2025.BMJ open diabetes research & care · 2025Review
- Boosting Immunity Through Nutrition and Gut Health: A Narrative Review on Managing Allergies and Multimorbidity.Nutrients · 2025Review
- Strengths and Limitations of BMI in the Diagnosis of Obesity: What is the Path Forward?Current obesity reports · 2024Review
- Observational cohort investigating health outcomes and healthcare costs after metabolic and bariatric surgery: a study protocol.BMJ open · 2024Article
- Clinical evaluation of patients living with obesity.Internal and emergency medicine · 2023Review
- Article
- TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.Hepatology forum · 2023Article
- Effects of intragastric balloon on obesity in obese Korean women for 6 months post removal.Nutrition research and practice · 2021Article
- Re-suturing after primary endoscopic sleeve gastroplasty (ESG) for obesity.Surgical endoscopy · 2021Article
- Increases in multimorbidity with weight class in the United States.Clinical obesity · 2021Article
- Energy Metabolism and Ketogenic Diets: What about the Skeletal Health? A Narrative Review and a Prospective Vision for Planning Clinical Trials on this Issue.International journal of molecular sciences · 2021Review
- Consensus on Medical Nutrition Therapy for Diabesity (CoMeND) in Adults: A South Asian Perspective.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- Article
- A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort.Journal of clinical medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewThe current medical model for obesity management is BMI-centric because BMI is the predominant measure used to gauge disease severity, as well as indications for various treatment modalities. Recent advancements in therapy and understanding of the relationship between BMI and obesity-related complications call for a re-examination of this approach. RECENT
findingsAdvancements in treatment, including the recent approval of two new weight loss medications in the USA, have enabled development of new medical models for management of obesity. On the basis of accumulating data demonstrating the benefits of weight loss regarding multiple obesity-related complications (e.g., diabetes prevention, type 2 diabetes mellitus, cardiovascular disease risk, nonalcoholic steatohepatitis, sleep apnea), a complications-centric model is proposed that employs weight loss as a tool to treat and prevent obesity comorbidities. This model assures that the aggressiveness of therapy is commensurate with disease severity, and that therapy is directed at those obese patients who will benefit most from weight loss therapy. The treatment algorithm is comprehensive in addressing complications and quantitative when possible in the staging of risk or disease severity. SUMMARY: A complications-centric approach to obesity management identifies patients who will benefit most from weight loss, and optimizes patient outcomes, benefit/risk ratio, and the cost-effectiveness of interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.